Font Size: a A A

Sharui Tan Synthesis And Process Study

Posted on:2006-08-30Degree:MasterType:Thesis
Country:ChinaCandidate:D LiuFull Text:PDF
GTID:2191360155462810Subject:Medicinal chemistry
Abstract/Summary:PDF Full Text Request
The incidence of asthma in the world has been increased rapidly, now The therapeutical drugs is still focusing on the drugs of inhalant steroidal for anti-inflammatory, the drugs for the dilation of bronchiole, such as β -2 adrenoceptor agonists, and the antiallergic drugs such as leukotriene antagonist. It is important to research the medicines of new mechanism. Many pharmaceutical companies have investigated the neurokinins antagonist. Neurokinin-2 receptors are expressed in the gastrointestinal tract of both laboratory animals and humans. Selective NK-2 receptor antagonist can inhabit the asthma and release the pain of patients.This article studied the preparation and the process of an important NK-2 antagonist — Saredutant. Now it progresses to phase Ⅱ clinical trial by Senofi-Synthelabo.Based on the analysis of the synthesis described in the reference, we firstly discover a new and more direct route to prepare the key medciate 3-cyano-3-(3,4-dichlorophenyl)propionic acid. In this route saredutant was prepared from simple starting material 3,4-dichlorophenyl-benzene carbonal, through 9 steps reaction including of condensation, addition, hydrolysis, decarboxylation, reduction by borane, resoluting by D-tartaric acid, acylation, hydroxy protecting, methylation of amine, cleavage of the protective group ,condensation with side chain . the overall yield is 7.87% .In this route the cost was prohibitively expensive due to more steps and the lower yield. So, we design a whole new route. In this route Saredutant was prepared from simple starting material 1,2-dichlorobenzene, through 7 steps reaction including of Friedel-Crafts reaction, Wittig reaction, substitution, hydrogenation reduction , resolution by D-tartaric acid, acylation , condensation with side chain, the overall yield is 11.7 %. There were 3 new compounds. The key mediate of 4-(N-methyl-N-benzyl)amine-3-(3,4-dichlorophenzyl)-2-ethyl crotonate can be reduced by asymmetric hydrogen, or reduced by hydrogen and then resoluted.The side chain of saredutant was prepared starting from 4-benzylpiperidone through 3 steps reaction including of Griguard reaction, Ritter reaction, hydrogenation, the overall yield is 52.5 %.The new compounds and the main mediates are identified by ~1HNMR, MS.
Keywords/Search Tags:Saredutant asthma, neurokinin receptor, neurokinin receptor, antagonist prepare, process
PDF Full Text Request
Related items